• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人实体器官移植后迟发性移植后淋巴细胞增生性疾病:病例系列及文献综述

Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature.

作者信息

Gandhi S, Behling E, Behrens D, Ferber A, Schwarting R, Budak-Alpdogan T

机构信息

MD Anderson Cancer Center at Cooper, Camden, NJ, USA.

Department of Pathology, Cooper University Hospital, Camden, NJ, USA.

出版信息

Case Rep Transplant. 2020 Feb 10;2020:8247308. doi: 10.1155/2020/8247308. eCollection 2020.

DOI:10.1155/2020/8247308
PMID:32095310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035525/
Abstract

The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that have wide variety of clinical and histological presentations. The management of PTLDs is challenging due to variety of involvement sites and histological types. The length and type of immunosuppression are correlated with the emergence of PTLDs, and most of the cases appear within the first two years after transplant. This case series describes five late-onset PTLDs with rare histological features and multiorgan involvement.

摘要

移植后淋巴细胞增生性疾病(PTLDs)是一组异质性肿瘤,具有多种多样的临床和组织学表现。由于受累部位和组织学类型的多样性,PTLDs的管理具有挑战性。免疫抑制的时长和类型与PTLDs的出现相关,且大多数病例出现在移植后的头两年内。本病例系列描述了5例具有罕见组织学特征和多器官受累的迟发性PTLDs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/27baaf0f1251/CRIT2020-8247308.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/d56bf9d1c25f/CRIT2020-8247308.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/bba5229910f2/CRIT2020-8247308.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/45417c9b0027/CRIT2020-8247308.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/27baaf0f1251/CRIT2020-8247308.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/d56bf9d1c25f/CRIT2020-8247308.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/bba5229910f2/CRIT2020-8247308.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/45417c9b0027/CRIT2020-8247308.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2d1/7035525/27baaf0f1251/CRIT2020-8247308.004.jpg

相似文献

1
Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature.成人实体器官移植后迟发性移植后淋巴细胞增生性疾病:病例系列及文献综述
Case Rep Transplant. 2020 Feb 10;2020:8247308. doi: 10.1155/2020/8247308. eCollection 2020.
2
Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.肾移植后极晚期淋巴细胞增殖性疾病经积极化疗后的持久缓解:单中心16例观察报告
J Clin Oncol. 2000 Nov 1;18(21):3622-32. doi: 10.1200/JCO.2000.18.21.3622.
3
Plasmacytoma-like posttransplant lymphoproliferative disorder following orthotopic liver transplantation: a case report.原位肝移植后浆细胞瘤样移植后淋巴组织增生性疾病:一例报告
Transplant Proc. 2011 Sep;43(7):2806-9. doi: 10.1016/j.transproceed.2011.07.004.
4
Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.移植后淋巴组织增生性疾病:1990-2009 年单中心 43 例临床病理分析。
Clin Transplant. 2012 Jan-Feb;26(1):67-73. doi: 10.1111/j.1399-0012.2010.01392.x. Epub 2011 Jan 27.
5
Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.实体器官移植受者中的爱泼斯坦-巴尔病毒相关T细胞淋巴瘤
Biomed Pharmacother. 2001 Sep;55(7):366-8. doi: 10.1016/s0753-3322(01)00081-6.
6
Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.肾胰联合移植受者的移植后淋巴细胞增生性疾病:宿主和供体来源的克隆性B淋巴细胞增殖同时发生。
Am J Surg Pathol. 2006 Jul;30(7):900-5. doi: 10.1097/01.pas.0000202165.67278.b3.
7
Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades.肾移植后迟发性移植后淋巴组织增生性疾病:三十年来的单中心研究。
Nephrol Dial Transplant. 2013 Feb;28(2):471-8. doi: 10.1093/ndt/gfs476. Epub 2012 Nov 4.
8
Expression of intratumoral forkhead box protein 3 in posttransplant lymphoproliferative disorders: clinical features and survival outcomes.移植后淋巴细胞增殖性疾病中肿瘤内叉头框蛋白3的表达:临床特征与生存结果
Transplantation. 2015 May;99(5):1036-42. doi: 10.1097/TP.0000000000000415.
9
Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.移植后淋巴细胞增生性疾病:经临床病理定制治疗后预后改善
Haematologica. 2002 Jan;87(1):67-77.
10
Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome.实体器官移植后晚期发生的淋巴瘤:治疗对临床结局的影响。
Transplantation. 2002 Oct 27;74(8):1095-102. doi: 10.1097/00007890-200210270-00007.

引用本文的文献

1
Posttransplant Lymphoproliferative Disorder in a Patient With Alpha-1 Antitrypsin Deficiency: A Case Report.α-1抗胰蛋白酶缺乏症患者的移植后淋巴细胞增生性疾病:一例报告
Cureus. 2024 Jun 10;16(6):e62107. doi: 10.7759/cureus.62107. eCollection 2024 Jun.
2
Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after Haematopoietic Stem Cell Transplant (HCT) - A Clinical Case.造血干细胞移植(HCT)后极晚发性移植后淋巴细胞增殖性疾病(PTLD)—— 1例临床病例
Mediterr J Hematol Infect Dis. 2024 May 1;16(1):e2024048. doi: 10.4084/MJHID.2024.048. eCollection 2024.
3
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol.

本文引用的文献

1
Post-Transplantation Lymphoproliferative Disorders in Adults.成人移植后淋巴增殖性疾病
N Engl J Med. 2018 Feb 8;378(6):549-562. doi: 10.1056/NEJMra1702693.
2
Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.移植后淋巴组织增生性疾病相关霍奇金淋巴瘤:临床特征、预后及生存的比较分析
Am J Hematol. 2016 Jun;91(6):560-5. doi: 10.1002/ajh.24346. Epub 2016 Apr 26.
3
Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center.
在多中心扩展准入方案中,异体造血干细胞移植或实体器官移植后 EBV+PTLD 应用 Tabelecleucel。
Blood Adv. 2024 Jun 25;8(12):3001-3012. doi: 10.1182/bloodadvances.2023011626.
4
Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients.实体器官移植受者移植后淋巴细胞增殖性疾病风险评分的开发与验证
Cancers (Basel). 2022 Jul 4;14(13):3279. doi: 10.3390/cancers14133279.
EB 病毒阴性移植后淋巴组织增生性疾病:来自单一中心的 3 个不同病例。
Turk J Haematol. 2014 Mar;31(1):79-83. doi: 10.4274/Tjh.2012.0010. Epub 2014 Mar 5.
4
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.移植后淋巴组织增生性疾病(PTLD):危险因素、诊断和当前治疗策略。
Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
5
A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.原发性中枢神经系统移植后淋巴组织增生性疾病的病例系列研究:影像学和临床特征。
Neurosurgery. 2013 Jun;72(6):960-70; discussion 970. doi: 10.1227/NEU.0b013e31828cf619.
6
Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.实体器官移植中的爱泼斯坦-巴尔病毒与移植后淋巴细胞增殖性疾病
Am J Transplant. 2013 Mar;13 Suppl 4:107-20. doi: 10.1111/ajt.12104.
7
Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.成人肾移植受者移植后淋巴组织增生性疾病的流行病学。
Transplantation. 2013 Feb 15;95(3):470-8. doi: 10.1097/TP.0b013e318276a237.
8
Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades.肾移植后迟发性移植后淋巴组织增生性疾病:三十年来的单中心研究。
Nephrol Dial Transplant. 2013 Feb;28(2):471-8. doi: 10.1093/ndt/gfs476. Epub 2012 Nov 4.
9
Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.成人肾和肾胰腺移植受者移植后淋巴组织增生性疾病的流行病学:法国登记处的报告和淋巴瘤亚组分析。
Am J Transplant. 2012 Mar;12(3):682-93. doi: 10.1111/j.1600-6143.2011.03896.x. Epub 2012 Jan 6.
10
Spectrum of cancer risk among US solid organ transplant recipients.美国实体器官移植受者的癌症风险谱。
JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.